Latest On Idorsia Ltd (IDRSF):
About Idorsia Ltd (IDRSF):
Idorsia Ltd, a biopharmaceutical company, discovers, develops, and commercializes drugs for unmet medical needs in Switzerland. The company has a clinical development pipeline that cover various therapeutic areas, including CNS, cardiovascular, and immunological disorders, as well as orphan diseases. Idorsia Ltd has a collaboration agreement with Janssen Biotech Inc. to jointly develop and commercialize aprocitentan and its derivative compounds or products; ReveraGen to research and co-develop vamorolone, a non-hormonal steroid modulator for the treatment of duchenne muscular dystrophy; and Hoffman-La Roche Inc. to develop and market compounds in the field of cancer immunotherapy. It also has a collaboration with Antares Pharma, Inc. for the development of a self- administered drug device product for Selatogrel; and Neurocrine Biosciences, Inc. to develop and commercialize ACT-709478, which is in Phase 1 clinical trial for the treatment of epilepsy. The company was incorporated in 2017 and is headquartered in Allschwil, Switzerland.
General
- Name Idorsia Ltd
- Symbol IDRSF
- Type Common Stock
- Exchange PINK
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Fiscal Year EndDecember
- Web URLhttp://www.idorsia.com
Valuation
- Price/Sales (Trailing 12 Mt.) 52.63
- Price/Book (Most Recent Quarter) 7.52
- Enterprise Value Revenue 60.83
Financials
- Most Recent Quarter 2020-12-31
- Return on Assets -21%
- Return on Equity -119%
- Earnings Per Share -$1.77
- Revenue Per Share $0
- Gross Profit -309318000
- Quarterly Earnings Growth 40.5%
Highlights
- Market Capitalization 4.77 billion
- Book Value Per Share $5.98
Share Statistics
- Shares Outstanding 166.45 million
- Shares Float 108.71 million
- % Held by Insiders 2925%
- % Held by Institutions 20.97%
Technicals
- Beta 0.75
- 52 Week High $33.83
- 52 Week Low $24.13
- 50 Day Moving Average 28.53
- 200 Day Moving Average 28.39
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
Idorsia Ltd (IDRSF) Dividend Calendar:
Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
---|
Idorsia Ltd (IDRSF) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
---|---|---|---|---|---|
2020-12-31 | 2020-12-31 | $5.82 million | -$0.94 | ||
2020-09-30 | 2020-12-31 | $7.77 million | -$0.96 | -$0.85 | -13.12% |
2020-06-30 | 2020-09-30 | $N/A | -$0.91 | -$0.82 | -10.46% |
2020-03-31 | 2020-06-30 | $5.02 million | -$0.54 | -$0.86 | 37.64% |
2019-12-31 | 2020-03-31 | $4.15 million | -$0.95 | -$1.00 | 4.97% |
2019-09-30 | 2019-12-31 | $6.56 million | -$1.12 | -$1.09 | -2.41% |
2019-06-30 | 2019-09-30 | $6.56 million | -$0.92 | -$0.99 | 7.53% |
2019-03-31 | 2019-06-30 | $6.56 million | -$0.98 | -$0.99 | 0.68% |
2018-12-31 | 2019-03-31 | $40.94 million | -$0.82 | ||
2018-09-30 | 2018-12-31 | $6.56 million | -$0.84 | -$0.79 | -6.43% |
2018-06-30 | 2018-09-30 | $8.62 million | -$0.94 | -$0.80 | -16.94% |
2018-03-31 | 2018-06-30 | $6.56 million | -$0.69 | -$0.80 | 14.18% |
2017-12-31 | 2018-03-31 | $256.15 million | -$0.69 | -$0.80 | 13.54% |
2017-09-30 | 2017-12-31 | $N/A | $0.54 | ||
2017-06-30 | 2017-09-30 | $N/A | -$0.61 | -$0.80 | 23.24% |
2017-03-31 | 2017-06-30 | $N/A | $1.15 | $0.00 | |
2016-12-31 | 2017-03-31 | -$0.96 | $0.00 |
Idorsia Ltd (IDRSF) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
Date |
---|
Research Development |
Income Before Tax |
Selling General Administrative |
Gross Profit |
Ebit |
Operating Income |
Income Tax Expense |
Total Revenue |
Cost of Revenue |
Total Other Income Expense Net |
Net Income From Continuing Operations |
Net Income Applicable to Common Shares |
Cash Flow:
Date |
---|
Investments |
Change to Liabilities |
Total Cash Flow from Investing Activities |
Net Borrowings |
Total Cash Flow from Financial Activities |
Change to Operating Activities |
Change in Cash |
Total Cash from Operating Activities |
Depreciation |
Other Cash Flow from Investing Activities |
Change to Inventory |
Change to Account Receivables |
Other Cash Flow from Financing Activities |
Change to Net Income |
Capital Expenditures |
Balance Sheet:
Date |
---|
Total Liabailities |
Total Stockholder Equity |
Other Current Liabilities |
Total Assets |
Common Stock |
Other Current Assets |
Retained Earnings |
Other Liabilities |
Other Assets |
Cash |
Total Current Liabilities |
Other Stockholder Equity |
Property, Plant & Equipment |
Total Current Assets |
Long Term Investments |
Net Tangible Assets |
Short Term Investments |
Long Term Debt |
Inventory |
Accounts Payable |
Idorsia Ltd (IDRSF) Chart:
Idorsia Ltd (IDRSF) News:
Below you will find a list of latest news for Idorsia Ltd (IDRSF) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Idorsia Ltd (IDRSF) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
---|
Idorsia Ltd (IDRSF) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
Date | Form Type | Form Name | Link |
---|